biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > About Share Price

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Apr 14, 2022 6:02pm

190 Views

Post# 34605410

RE:RE:RE:About Share Price

I'm more PO at the lack of market interest than what the expectations & excitement of others is as there should be a somewhat healthy dose of excited & optimism given what's unfolded/unfolding??

Lack of interest is no surprise IMO. The market doesn't get excited about what might happen somewhere down the road. The J&J deal is good but for unknown drugs on an unknown time frame. It will take specific news of an immenent clinical trial or possibly a big milestone payment to generate any excitement.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages